Michael D. Clayman, President and CEO at Flexion Therapeutics Inc (FLXN), bought 20,000 shares at $22.33 ($447K) on 2018-08-09, disclosed to the SEC on 2018-08-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.33 | 10,000 | $223K | 50.0% |
| 2 | $22.33 | 10,000 | $223K | 50.0% |
| Total | $22.33 avg | 20,000 | $447K | 100% |
| Filing → |
| FLXN | BUY | 2019-05-13 | $100K | — | Filing → |
| FLXN | BUY | 2019-03-13 | $100K | — | Filing → |
| FLXN | SELL | 2019-01-04 | $41K | — | Filing → |